84.1% of participants in the first study, 89.5% of participants in the second, and 88.9% of participants in the third were within normal blood sugar ranges after taking semaglutide for 68 weeks
Medical Necessity Checklist for Formulary Exception If you're requesting a formulary exception, gather this documentation first: Required Documentation for Exception Request Current BMI documentation (30 or 27 with comorbidity) Documented comorbidities with ICD-10 codes: Obesity Class I/II/III (E66.811, E66.812, E66.813) Hypertension (I10) Type 2 Diabetes (E11) Dyslipidemia (E78.5) Obstructive Sleep Apnea (G47.33) Failed alternative treatments documented trials of: Phentermine or diethylpropion Qsymia or Contrave Semaglutide (Wegovy/Ozempic) for 6+ months Lifestyle modification records (diet/exercise program participation) Weight history showing chronic obesity (past 1-2 years) Letter of Medical Necessity from your Kaiser provider For more on prior auth documentation, see our Zepbound prior auth checklist EXCEPTION PATHWAYS How Some Members Get Coverage While standard coverage is limited, some Kaiser members do get Zepbound covered
Experienced doctors, like those at 61Five Health & Wellness, often have a track record of helping patients achieve long-term success
This hybrid strategy allows you to achieve faster weight loss while building habits that support long-term success
Semaglutide slows gastric emptying, which increases aspiration risk during anesthesia
Do not rub or massage the injection site immediately after administering Saxenda, as this may cause irritation or affect absorption
